Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Climate Anxiety × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Cognitive Dysfunction 1

Interventions

Surveys and Questionnaires 456 Blood Specimen Collection 372 Surgical Procedures, Operative 133 Radiotherapy 126 Observation 121 Interviews as Topic 120 Drug Therapy 118 Gene Expression Profiling 114 Biopsy 99 Magnetic Resonance Spectroscopy 96 Immunohistochemistry 90 Data Collection 85 Polymerase Chain Reaction 75 Specimen Handling 69 Amplified Fragment Length Polymorphism Analysis 69 Microarray Analysis 65 Bevacizumab 63 Magnetic Resonance Imaging 60 Watchful Waiting 59 Neoadjuvant Therapy 58 Flow Cytometry 55 Nivolumab 52 Immune Checkpoint Inhibitors 52 Therapeutics 50 pembrolizumab 45 Reverse Transcriptase Polymerase Chain Reaction 45 Positron Emission Tomography Computed Tomography 41 Radiosurgery 40 Liquid Biopsy 40 Ultrasonography 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡